About
For more than two decades, David has built a distinguished career in the Life Sciences…
Activity
7K followers
-
David Leroux-Petersen reposted thisDavid Leroux-Petersen reposted thisCorealis Pharma Inc. is attending CPHI Milan 2026, 𝘖𝘤𝘵𝘰𝘣𝘦𝘳 6–8. CEO David Leroux-Petersen will be in Milan, connecting with the global pharmaceutical community and discussing what’s next in drug development and manufacturing. If you’re attending CPHI Milan and want to talk oral solid dose development, clinical manufacturing, or how Corealis Pharma Inc. can help move your program from concept toward commercialization, connect with David Leroux-Petersen while you’re there. Book a meeting with David here: info@corealispharma.com #CPHI2026 #CPHIMilan #CorealisPharma #CDMO #DrugDevelopment #Pharma #OralSolidDose #ClinicalManufacturing
-
David Leroux-Petersen reposted thisDavid Leroux-Petersen reposted thisCorealis Pharma Inc. a hâte de participer à BIOHorizon 2026! Patrick Frankham, PhD, MBA représentera Corealis Pharma Inc. à 𝗕𝗜𝗢𝗛𝗼𝗿𝗶𝘇𝗼𝗻 𝟮𝟬𝟮𝟲, qui aura lieu les 7 et 8 octobre au Centre des congrès Sheraton Laval, à Laval, Québec. Organisé conjointement par BIOQuebec et Montréal InVivo, BIOHorizon est un nouvel événement phare qui réunira des leaders, décideurs, chercheurs, investisseurs et entrepreneurs de l’écosystème québécois des sciences de la vie et des technologies de la santé. En tant que fier membre de BIOQuebec, Corealis Pharma Inc. est heureux de prendre part à ces deux journées d’échanges, de rencontres et d’occasions de créer de nouveaux partenariats au sein de l’industrie. Vous serez à BIOHorizon? Venez rencontrer Patrick Frankham, PhD, MBA pour discuter de vos besoins en développement de formes pharmaceutiques orales solides et découvrir comment Corealis Pharma Inc. peut soutenir votre programme, du développement de formulations à un stade précoce jusqu’à la fabrication clinique BPF et à l’approvisionnement clinique. #CorealisPharma #BIOHorizon2026 #BIOQuébec #SciencesDeLaVie #Biotech #CDMO #DéveloppementDeMédicaments #DéveloppementDeFormulations #FabricationClinique
-
David Leroux-Petersen reposted thisDavid Leroux-Petersen reposted this𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗣𝗲𝗱𝗶𝗮𝘁𝗿𝗶𝗰 𝗗𝗿𝘂𝗴 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 Developing oral drug products for children brings a different set of challenges. From limited API availability and very low dose strengths to tablet size, palatability and age-appropriate dosage forms. At Corealis Pharma Inc., we bring 21 years of pediatric oral drug development experience, with 40+ projects supporting FDA NDA submissions and three commercial products serving pediatric patients worldwide. Our pediatric development capabilities include: • 𝗔𝗣𝗜-𝘀𝗽𝗮𝗿𝗶𝗻𝗴 𝗳𝗼𝗿𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁, with rapid screening using less than 200 g of API • 𝗩𝗲𝗿𝘆 𝘀𝗺𝗮𝗹𝗹 𝘁𝗮𝗯𝗹𝗲𝘁𝘀, including 2, 3, 4 and 5 mm formats • Expertise in 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗶𝗻𝗴 𝗹𝗼𝘄-𝗱𝗼𝘀𝗲 𝗳𝗼𝗿𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀 requiring high content uniformity • 𝗧𝗮𝘀𝘁𝗲-𝗺𝗮𝘀𝗸𝗶𝗻𝗴 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀 designed to improve pediatric acceptability • Flexible dosage forms, including 𝗳𝗮𝘀𝘁-𝗱𝗶𝘀𝘀𝗼𝗹𝘃𝗶𝗻𝗴 𝗮𝗻𝗱 𝗿𝗲𝗰𝗼𝗻𝘀𝘁𝗶𝘁𝘂𝘁𝗲𝗱 𝗳𝗼𝗿𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀 • 𝗣𝗲𝗱𝗶𝗮𝘁𝗿𝗶𝗰-𝗳𝗼𝗰𝘂𝘀𝗲𝗱 𝗮𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝗮𝗹 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁, including dissolution testing in physiologically relevant media such as beverages and juices • Integrated development through 𝗚𝗠𝗣 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴, with batch sizes starting at just 1,000 tablets or capsules 𝘉𝘦𝘤𝘢𝘶𝘴𝘦 𝘱𝘦𝘥𝘪𝘢𝘵𝘳𝘪𝘤 𝘥𝘳𝘶𝘨 𝘥𝘦𝘷𝘦𝘭𝘰𝘱𝘮𝘦𝘯𝘵 𝘥𝘦𝘮𝘢𝘯𝘥𝘴 𝘱𝘳𝘦𝘤𝘪𝘴𝘪𝘰𝘯 𝘢𝘵 𝘦𝘷𝘦𝘳𝘺 𝘴𝘤𝘢𝘭𝘦. 𝗙𝗿𝗼𝗺 𝗳𝗼𝗿𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝘁𝗼 𝗮 𝗯𝗿𝗶𝗴𝗵𝘁𝗲𝗿 𝘁𝗼𝗺𝗼𝗿𝗿𝗼𝘄. #CorealisPharma #PediatricDrugDevelopment #FormulationDevelopment #DrugDevelopment #Pharma #CDMO #OralSolidDose #PediatricFormulations
-
David Leroux-Petersen reposted thisDavid Leroux-Petersen reposted thisA new chapter begins at Biodextris. We’re pleased to announce the appointment of Clement Fourny as Chief Executive Officer of Biodextris. Clement brings over 20 years of commercial leadership experience in the life sciences and healthcare industries, having held senior positions at SmartLabs and Cytiva. His expertise in commercial strategy, partnerships, and biologics manufacturing will be instrumental in steering Biodextris as it embarks on its next growth journey. “Clement is exactly the leader Biodéxtris needs at this stage of our journey. His track record in building commercial organizations, securing landmark partnerships, and — above all — his ability to develop and empower teams to innovate, make him the ideal CEO to lead our next chapter.” — Nir Nimrodi, Executive Chairman, Biodextris We’re proud of how far Biodextris has come and excited to welcome Clement as we build what comes next. https://lnkd.in/gWWYsVAZ #Biodextris #Biotech #Biopharma #CDMO #Biomanufacturing #LifeSciences #Leadership
-
David Leroux-Petersen reposted thisDavid Leroux-Petersen reposted thisJoin Corealis Pharma Inc. in 𝘋𝘶𝘳𝘩𝘢𝘮 for an evening of great conversations, new connections, and small molecule CMC networking! Corealis Pharma Inc., Triclinic Labs, LLC., and Rottendorf Pharma are bringing together industry colleagues for the RTP Small Molecule CMC Networking Event at Tobacco Wood Brewing. Hosted by David Kwajewski of Corealis Pharma Inc., Joanna Bis of Triclinic Labs, LLC., and Christian Ahlmark of Rottendorf Pharma. Come connect with fellow CMC and drug development professionals in a relaxed setting. Food and drinks are on us! RSVP for tickets with David Kwajewski before it's sold out. #CorealisPharma #TriClinicLabs #RottendorfPharma #CMC #SmallMolecule #DrugDevelopment #Pharma #Biotech #RTP #Networking #DurhamNC
-
David Leroux-Petersen reposted thisDavid Leroux-Petersen reposted thisTomorrow in New Brunswick — Contract Pharma's 25th Annual Contracting & Outsourcing Conference opens September 24, and Dow Development Labs will be there. If topical or semi-solid formulation is on your roadmap, let's use the time well. We're always glad to talk through what it takes to move a program from early development into reliable cGMP production. Attending? Send us a message and we'll find time to connect. Details — link in the comments. #ContractPharma #CDMO #TopicalDrugDelivery #DrugDevelopment
-
David Leroux-Petersen shared thisQuelle belle semaine à l’occasion de la Biotech Week ! Un grand merci à Noah Ouellette et Olivia Dion du bureau de Boston d’Investissement Québec pour leur soutien et leur collaboration tout au long de l’événement. Merci également à Investissement Québec d’avoir accueilli la réception de Corealis Pharma Inc. hier soir!!
-
David Leroux-Petersen reposted thisDavid Leroux-Petersen reposted thisWe’re pleased to announce our collaboration with PhinC Group, bringing PBBM/PBPK predictive modeling directly into early oral formulation development. By combining Corealis Pharma Inc.s’ formulation and manufacturing expertise with PhinC’s predictive modeling capabilities, we’re helping sponsors make smarter development decisions earlier, focus experiments where they matter most, and reduce formulation risk. Read the full announcement on Business Wire: #CorealisPharma #PhinCGroup #DrugDevelopment #FormulationDevelopment #PBBM #PBPK #CDMO #BiotechCorealis Pharma and PhinC Group Collaborate to Bring Predictive Modeling into Early Formulation DevelopmentCorealis Pharma and PhinC Group Collaborate to Bring Predictive Modeling into Early Formulation Development
-
David Leroux-Petersen reposted thisDavid Leroux-Petersen reposted thisPlongez au cœur de l’industrie avec le Circuit C : CDMO/CRO, de la Journée internationale de BIOHorizon 2026 ! Au programme : une journée immersive à la découverte d’acteurs, d’entreprises et d’infrastructures qui contribuent au développement et à la production de solutions innovantes en sciences de la vie au Québec. 🔬 Au fil de la journée : 🔹 Visite de Corealis Pharma Inc. et IQVIA Laboratories 🔹 Découverte de Biodextris et Dynacare 🔹 Visite de la Cité de la Biotech 🔹 Présentation de Jean-Marc J. (Cité de la Biotech) 🔹Déjeuner au Mila - Institut québécois d'intelligence artificielle avec les participants des trois circuits 🔹 Visite de Sygnature Discovery 🔹 Découverte de Royalmount Biopharma Services • Services Biopharma Royalmount La journée se conclura par une réception de réseautage à l’hôtel de ville de Montréal, réunissant les délégations internationales et professionnels de l’industrie québécoise, avant le lancement officiel de BIOHorizon 2026. 📅 6 octobre 2026 📍 Montréal 🔗 www.bio-horizon.com ⚠️ À noter : Pour des raisons de logistique, la Journée internationale est réservée aux entreprises et organismes provenant de l’extérieur du Québec. ___________ Dive into the heart of the industry with Track C: CDMO/CRO, part of the International Day of BIOHorizon 2026 ! The program includes an immersive day discovering the organizations, companies and infrastructures contributing to the development and production of innovative life sciences solutions in Québec. 🔬 Throughout the day: 🔹 Visit Corealis and IQVIA Labs 🔹 Discover Biodextris and Dynacare 🔹 Visit the Cité de la Biotech 🔹 Presentation by Jean-Marc Juteau (Cité de la Biotech) 🔹 Lunch at MILA with with participants from the three tracks 🔹 Visit Sygnature Discovery 🔹 Discover Royalmount Biopharma Services The day will conclude with a networking reception at Montréal City Hall, bringing together international delegations and Québec industry professionals, ahead of the official launch of BIOHorizon 2026. 📅 October 6, 2026 📍 Montréal 🔗 www.bio-horizon.com ⚠️ Please note: For logistical reasons, the International Day is reserved for companies and organizations from outside Québec. #BIOHorizon2026 #SVTS #Innovation #Montréal
David Leroux-Petersen commented on a post
1mo
Great interview Aaron Morris. My sister‑in‑law has struggled with PCOS and hyperandrogenic symptoms for years, so truly wishing the PostEra team success with this promising candidate. Exciting times ahead!
-
David Leroux-Petersen liked thisDavid Leroux-Petersen liked thisPharmAla Biotech announces three corporate updates. Link to the press release in the comments below 👇 $mdma #psychedelics
-
David Leroux-Petersen liked thisDavid Leroux-Petersen liked thisLooking back on a great week at Biotech Week Boston! 🧬 It was a great opportunity to connect with people from across the biotech community to talk about the innovations shaping our industry. And of course, we couldn’t pass up the opportunity to bring back ‘KreaRun: Midweek Momentum’ for its second edition! 🏃♀️ A group of people from different backgrounds, companies and corners of the biotech community coming together for a few miles, good conversation and plenty of laughs. That’s what the #KreaRun community is all about. A big thank you to everyone who took the time to meet and run with us. We had a great time, Boston. Until next time! 💙 #MidweekMomentum #BiotechWeekBoston #LSXUSA #RESI
-
David Leroux-Petersen liked thisDavid Leroux-Petersen liked this📍 𝐂𝐏𝐇𝐈 𝐌𝐢𝐥𝐚𝐧 𝐢𝐬 𝐚𝐥𝐦𝐨𝐬𝐭 𝐡𝐞𝐫𝐞. Next week, the Bora Pharmaceuticals team will be in Milan to meet with customers and partners from around the world. We're looking forward to discussing your development and manufacturing goals and exploring how Bora can support your next program. If you haven't already, there's still time to schedule a meeting before the show. 📍 Visit us at Booth #12C49 or schedule a meeting: https://boracdmo.com/cphi/ Be sure to connect with our team while you're at CPHI Milan: Bobby Sheng Kirk Donaldson Helen Clark Jennifer Karlsson Laura Pandolfi Robert Evans Timothy Lane
-
David Leroux-Petersen liked thisDavid Leroux-Petersen liked this365 days at Bora. A year in, I’ve had the opportunity to understand what makes Bora Pharmaceuticals different and why clients choose to stay. They value the white-glove service, speed of execution, and deep FDA expertise, combined with our dual-source capabilities across Taiwan and the USA. It’s great to see how often a client comes to us for one product and, over time, expands the relationship. They start with an OSD, and then discover our capabilities across ophthalmics, injectables, semi-solids, and liquids. It’s a combination of breadth, agility, and execution that allows us to be more than a supplier: we aim to be a long-term partner. One year in, and there’s plenty more to come. Next stop: CPHI Milan! Looking forward to reconnecting with existing partners, meeting new ones, and continuing the conversation around how we can support the next stage of your growth. #CDMO #anniversary
-
David Leroux-Petersen liked thisDavid Leroux-Petersen liked thisCorealis Pharma Inc. is attending CPHI Milan 2026, 𝘖𝘤𝘵𝘰𝘣𝘦𝘳 6–8. CEO David Leroux-Petersen will be in Milan, connecting with the global pharmaceutical community and discussing what’s next in drug development and manufacturing. If you’re attending CPHI Milan and want to talk oral solid dose development, clinical manufacturing, or how Corealis Pharma Inc. can help move your program from concept toward commercialization, connect with David Leroux-Petersen while you’re there. Book a meeting with David here: info@corealispharma.com #CPHI2026 #CPHIMilan #CorealisPharma #CDMO #DrugDevelopment #Pharma #OralSolidDose #ClinicalManufacturing
-
David Leroux-Petersen liked thisDavid Leroux-Petersen liked thisPiramal Pharma Solutions’ Aurora, Canada drug substance site has received a $1,753,620 investment from the Ontario government, enabling it to upgrade site infrastructure and commercialize Ontario-made health technologies for new markets. ➡️ https://hubs.li/Q04yJZx-0 #pharmanews #drugsubstance #canadalifecience
-
David Leroux-Petersen liked thisDavid Leroux-Petersen liked thisHeading to CPHI Milan next week. I look forward to connecting with colleagues, meeting new partners and discussing where we can make a meaningful difference for patients. Proud to work alongside Precia Group, Argonaut Manufacturing Services Inc., AST, Consigli Construction Co., Inc., Expertly, Innovative Consulting Inc (ICI) and Engage Work. If you’ll be there, let’s find time to connect: https://lnkd.in/g9pXJys3 #CPHIMilan #LifeSciences
-
David Leroux-Petersen liked thisDavid Leroux-Petersen liked thisIn a fireside chat with WTR’s Robert Sassoon at the WTR Virtual Insights Conference, PharmAla Biotech Inc. (MDMA.CSE) CEO Nick Kadysh discusses: 1. Global clinical-grade MDMA supply and repeat clinical-trial customers 2. The company’s drugs-for-data strategy and rights to clinical outcomes 3. ALA-002, APA-01 and potential asset monetization opportunities Report with the full transcript: https://lnkd.in/gPx3YtKd On demand: https://lnkd.in/ghBx9KQw Request meeting: https://lnkd.in/gjY_iMaA #PharmAla #MDMA #MDXXF #Biotech #Psychedelics #Healthcare #WTRInsights
Experience & Education
Courses
-
Business Sustainability, 2012
University of Illinois
-
Business Writing for Managers, 2012
McGill Executive
-
Conseil du bâtiment durable du Québec
June 15, 2015
-
Enhancing the Sales Message, 2012
PA Consulting Group Inc
-
Green Chemistry Workshop
Presented NRC - May 2015
-
Innovative Green Building Products
Construct Canada, 2014
-
Licensing & IP Seminar
Licensing Quebec, 2014
-
Licensing Executives Society 2014
Member - Montreal
-
Member of International Nanotechnology Division’s Producers Committee
2015 TAPPI
-
Strategic Planning & Execution
McGill Executive, 2015
-
Writing in the Sciences, 2012
Standford University
Honors & Awards
-
Food & Consumer Products of Canada
Partner in Associate Program
-
NRC Organizational Excellence Award
National Research Council Canada
-
Instant Award - Conference Strategy & Execution
Aquatic & Crop Resource Development Portfolio
-
Process Innovation
National Research Council Canada - Business Management
-
New Business Achievement Award
Charles River Laboratories
-
Sales Excellence Award
Charles River Laboratories
Languages
-
English
-
-
French
-
Organizations
-
Food and Consumer Products of Canada
Associate Member Program
Explore more posts
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More